Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
0-7-21 radiation therapy for the treatment of canine oral melanomaBateman, K.E. (University of Guelph, Guelph, Ontario) ; Catton, P.A ; Pennock, P.W ; Kruth, S.AJournal of veterinary internal medicine, 1994-07, Vol.8 (4), p.267-272 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
0% Greenhouse Gas Emissions - Do We Want Them?Wheeler, JimSupply House Times, 2007-11, Vol.50 (9), p.78Troy: BNP MediaTexto completo disponível |
3 |
Material Type: Imagem
|
![]() |
|
4 |
Material Type: Artigo
|
![]() |
00005 Urine tumor DNA detects minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomyChen, Kevin ; Chauhan, Pradeep S. ; Babbra, Ramandeep K. ; Feng, Wenjia ; Kim, Eric H. ; Smith, Zachary L. ; Arora, Vivek K. ; Chaudhuri, Aadel A.Journal of clinical and translational science, 2021-03, Vol.5 (s1), p.113-114 [Periódico revisado por pares]Cambridge, UK: Cambridge University PressTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
0001 ANALYSIS OF THE ENTIRE HLA REGION IN SUSCEPTIBILITY FOR CERVICAL CANCER: A COMPREHENSIVE STUDYvan der Zee, A. G. ; Nolte, I. J. ; Zoodsma, M. ; Schipper, M. ; Steege, G. Ter ; Oosterom, E. ; de Vries, E. G. ; Te Meerman, G. J.International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.51-51 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
0001: Intraperitoneal Chemotherapy Improves Survival and Disease-Free Interval From Ovarian Cancer: A Meta-Analysis of Randomised TrialsJaaback, K. S. ; Johnson, N.International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.599-599 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
00010 ANTIANGIOGENESIS - A NEW TREATMENT MODALITY FOR OVARIAN CANCER PATIENTSSchröder, W. ; Abadie, S. ; Witteveen, P. O. ; Campone, M. ; Viens, P. ; Jalava, T. ; Masson, E. ; Bilic, S. ; Chlistalla, A. ; du Bois, A.International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.53-54 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
000101 PACLITAXEL/CARBOPLATIN (TC) VS. PACLITAXEL/CARBOPLATIN FOLLOWED BY TOPOTECAN (TOP) IN FIRST-LINE TREATMENT OF OVARIAN CANCER FIGO STAGES IIB-IV. MATURE RESULTS OF AN INTERGROUP PHASE III TRIALLück, H. J. ; Weber, B. ; Quaas, J. ; Lortholary, A. ; SchadeBrittinger, C. ; Richter, B. ; Bourgeois, H. ; Kuhn, W ; Meyer, F. ; Pfisterer, J.International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.79-79 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
000102 PROGRESS IN THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UKFOCSS)Jacobs, I. J. ; Mackay, J. ; Rosenthal, A. N. ; Fraser, L. ; Perault, L. ; Mozersky, J. ; Skates, S. J. ; Menon, U.International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.80-80 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
000103 PACLITAXEL-CARBOPLATIN-GEMCITABINE VS. PACLITAXEL-CARBOPLATIN AS FIRSTLINE TREATMENT OF OVARIAN CANCER: A RANDOMIZED PHASE III GCIG INTERGROUP STUDY (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102)du Bois, A. ; Schroeder, W. ; Jelic, S. ; Weber, B. ; Sehouli, J. ; Keern, J. ; Priou, F. ; Huober, J. ; Railing, M. ; Ray-Coquard, I. ; Heilmann, V. ; Surges, A. ; Pfisterer, J. ; Gropp, M. ; Staehle, A. ; Wimberger, P. ; Jackisch, C. ; Mueller, H. H.International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.80-80 [Periódico revisado por pares]Oxford: BMJ Publishing Group LTDTexto completo disponível |